July 2025
National Intern Day
Celebrate AMCP Foundation Summer Interns and learn more about upcoming internship opportunities.
Meet the AMCP Foundation 2025 Interns
Learn more about Internship Opportunities
July 2025
Overview of an Investigational Adjunctive Therapy for Adults with Major Depressive Disorder
A Pre-Approval Information Exchange (PIE) Webinar, presented by Intra-Cellular Therapies, Inc.
During this webinar, the burden of disease in patients with major depressive disorder will be discussed, along with the efficacy and safety results from the two Phase 3 trials and a long term-safety trial. These results formed the basis for sNDA FDA submission. There will be a live Q&A to allow for interactive discussion.
This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions®.
This product is in the clinical evaluation stage for MDD and has not been approved for that use by the FDA. The safety and efficacy of this product for MDD have not been established.
July 2025
The Science Behind an Investigational Oral BTKi, for Primary ITP: Pre-Approval Information Exchange (PIE)
A Pre-Approval Information Exchange (PIE) Webinar, presented by Sanofi.
Join us for an in-depth discussion on the unmet needs and burden of disease for patients with persistent or chronic primary immune thrombocytopenia (ITP). This webinar will explore the role of inflammation in ITP pathophysiology, and will also examine the mechanism of action of a novel investigational Bruton’s tyrosine kinase inhibitor (BTKi) and review key efficacy and safety findings from the LUNA 3 Clinical Program. The session will conclude with a live Q&A.
This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions®.
This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.
July 2025
2025 Medicare Proposed Rule: Physician and Outpatient Fee Schedules
An AMCP Member Webinar
This webinar will discuss the major components of the recently-released 2025 Medicare Physician Fee Schedule and Hospital Outpatient Prospective Payment System proposed rules.
July 2025
The Impact of IBD: A Patient’s Journey
A Science & Innovation Webinar, presented by Abbvie.
Inflammatory Bowel Disease (IBD) is a chronic, unpredictable, inflammatory disorder of the digestive tract associated with major clinical and economic burden. IBD is a progressive disease that can damage the bowel over time and lead to hospitalizations, surgeries, and disability. There is a multifaceted burden of IBD on patients, compounded by distressing, debilitating symptoms which can extend to familial and social impacts. This webinar is designed to highlight the impact of living with IBD through the lens of the patient.
July 2025
One, Big Beautiful Webinar: Understanding the Impact of HR 1 on Managed Care
Join us for One, Big Beautiful Webinar, a timely and essential session exploring the sweeping implications of H.R. 1 on the managed care landscape. This webinar will unpack the legislation’s most consequential provisions, including projected reductions in federal outlays, shifts in enrollments, and the anticipated rise in uninsured populations. Whether you’re a payer, policymaker, or pharmacy leader, this session will equip you with the insights needed to navigate the evolving regulatory environment and advocate for sustainable, patient-centered care.
July 2025
Bensocatib Pre-Approval Information Exchange
A Pre-Approval Information Exchange (PIE) Webinar, presented by Insmed.
Wael ElMaraachli, MD, of University of California, San Diego Health, and Kheelan Gopal, PharmD, of Insmed Medical, will present a webinar on bensocatib, an investigational, first-in-class treatment for non-cystic fibrosis bronchiectasis. In this presentation, they will provide an overview of this chronic and progressive inflammatory disease, and will share clinical trial data on brensocatib.
This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions®.
This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.
June 2025
2026 Call for AMCP Board Applications
Each year, AMCP invites dedicated AMCP members to apply for leadership roles on the AMCP Board of Directors. Serving on the Board is a unique opportunity to shape the future of managed care pharmacy, contribute to AMCP’s strategic direction, and represent the voice of approximately 8,000 members.
AMCP is currently seeking candidates for the following positions for the 2026–2027 Board Slate:
President-elect
Three (3) At-large Directors
Application Deadline: Friday, August 1, 2025, at 11:59 PM ET
MEMBERS
June 2025
AMCP Market Insights: Managed Care Approaches to Bispecific Antibodies
An AMCP Market Insights Webinar
Join us for a webinar on the managed care approaches to Bispecific Antibodies (BsAbs), focusing on follicular Lymphoma (FL) and diffuse large B-cell lymphoma (DLBCL). This session will feature clinical managed care participants from the roundtable convened by AMCP in April 2025. Presenters will examine the cost-effectiveness of BsAbs compared to alternative treatment pathways for FL and DLBCL, explore payer perspectives on the role of BsAbs, review clinical trial results and real-world evidence for BsAbs, gain insights into best practices for MCOs in managing BsAbs effectively, and provide an update on the unique science, mechanisms of action and dosing protocols of BsAbs.
June 2025
The Modern Healthcare Decision Maker’s Guide to Drug Review and Formulary Insights
An AMCP Webinar, hosted by FormularyDecisions®
In today’s rapidly evolving health care landscape, 89% of health care decision-makers (HCDMs) use digital channels as a key source of information in decision-making. Are you interested in exploring tools to streamline how you gather sources, review drug information, and learn from peer perspectives? Join FormularyDecisions | Cencora, in partnership with AMCP, for an overview of FormularyDecisions®. This online platform streamlines the product review process and provides HCDMs complimentary access to evidence on pipeline and FDA-approved products.